Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
How IPO-bound Gland Pharma's valuation spiked under China's Fosun
China’s Shanghai Fosun Pharmaceutical Group, which acquired a majority stake in Gland Pharma Ltd less than three years ago,...
Healthcare
Quadria founders' healthcare VC fund eyes much bigger corpus for second vehicle
Healthcare-focused venture capital firm Healthquad Advisors Pvt. Ltd is planning a second outing that could be almost six times...
Finance
Bank of Baroda, other lenders count cost of loans in NMC Health collapse
As the crisis engulfing his business empire deepened, Bavaguthu Raghuram Shetty met with Bank of Baroda officials in mid-March...
Healthcare
Value Lens: Piramal Pharma stake comes at some discount but may almost lose that tag
Private equity firm Carlyle has agreed to buy a fifth of Piramal Enterprises Ltd’s pharmaceutical business at some discount...
Healthcare
After three new India bets, Carlyle exits healthcare services firm
Private equity firm The Carlyle Group, which made three new India investments over the past two months, has fully exited ......
Healthcare
Value lens: JB Chemicals looks discounted in KKR's control deal
Global private equity firm KKR’s deal to acquire a controlling stake in JB Chemicals & Pharmaceuticals Ltd values the...
Healthcare
KKR to acquire controlling stake in JB Chemicals for over $410 mn
Global alternative asset manager KKR has agreed to purchase a controlling stake in JB Chemicals & Pharmaceuticals Ltd in its...
Healthcare
Metropolis Healthcare's deal to acquire Gujarat diagnostics firm collapses
Pathology chain Metropolis Healthcare Ltd’s plan to acquire a majority stake in a Gujarat-based diagnostics company has...
Healthcare
PE-backed specialised diagnostics firm Lilac eyes fresh funding for expansion
Specialised diagnostics company Lilac Insights Pvt. Ltd, which had raised its first private equity funding three years ago, is...
Healthcare
Warburg Pincus exits its sole pharmaceutical bet in India
US-based private equity firm Warburg Pincus has exited a Mumbai-listed drugmaker, the only pharmaceutical company in its India...
